Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReadiSorb is a specialized healthcare company focused on the development of liposomal delivery systems for nutritional supplements. The company is best known for its flagship product, ReadiSorb Liposomal Glutathione, which utilizes a proprietary encapsulation technology to enhance the absorption and bioavailability of the body's master antioxidant. Founded by Dr. Timothy Guilford, ReadiSorb bridges the gap between nutraceuticals and clinical science by participating in peer-reviewed research on oxidative stress and immune health. Their products are widely utilized by healthcare professionals to support patients with chronic conditions, including autism spectrum disorder and environmental toxicities. The company operates out of Palo Alto, California, maintaining a focus on high-purity, clinically validated formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReadiSorb.